{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:26:05Z","timestamp":1761841565140},"reference-count":41,"publisher":"SLACK, Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Refract Surg"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To compare photorefractive keratectomy (PRK) with prophylactic use of mitomycin C (MMC) and LASIK in custom surgeries for myopic astigmatism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Eighty-eight eyes of 44 patients with a minimum estimated ablation depth of 50 \u00b5m were randomized to receive PRK with MMC 0.002% for 1 minute in one eye and LASIK in the fellow eye. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), cycloplegic refraction, slit-lamp microscopy, contrast sensitivity, specular microscopy, aberrometry, and a subjective questionnaire were evaluated. Forty-two patients completed 6-month follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>\n              Mean spherical equivalent refraction error before surgery and mean ablation depth were \u22123.99\u00b11.20 diopters (D) and 73.09\u00b114.55 \u00b5m in LASIK eyes, and \u22123.85\u00b11.12 D and 70.7\u00b114.07 \u00b5m in PRK with MMC eyes, respectively. Uncorrected visual acuity was significantly better in PRK with MMC eyes 3 months (\n              <jats:italic>P<\/jats:italic>\n              =.04) and 6 months (\n              <jats:italic>P<\/jats:italic>\n              =.01) after surgery. Best spectacle-corrected visual acuity and spherical equivalent refraction did not differ significantly in the groups during follow-up (\n              <jats:italic>P<\/jats:italic>\n              &gt;.05). Significant haze was not observed in any PRK with MMC eye. Mean higher order aberration was lower in PRK with MMC eyes postoperatively compared with LASIK eyes (\n              <jats:italic>P<\/jats:italic>\n              =.01). Better contrast sensitivity was observed in PRK with MMC eyes than LASIK eyes (\n              <jats:italic>P<\/jats:italic>\n              &lt;.05). The endothelial cell count did not differ significantly between groups (\n              <jats:italic>P<\/jats:italic>\n              =.65). In terms of visual satisfaction, PRK with MMC eyes were better rated.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>\n              Photorefractive keratectomy with MMC appears to be more effective than LASIK in custom surgery for moderate myopia. During 6-month follow-up, no toxic effects of MMC were evident. Long-term follow-up is necessary to attest its safety. [\n              <jats:italic>J Refract Surg<\/jats:italic>\n              . 2008;24:326\u2013336.]\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.3928\/1081597x-20080401-03","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T21:26:04Z","timestamp":1549574764000},"page":"326-336","source":"Crossref","is-referenced-by-count":35,"title":["Photorefractive Keratectomy With Mitomycin C Versus LASIK in Custom Surgeries for Myopia: A Bilateral Prospective Randomized Clinical Trial"],"prefix":"10.3928","volume":"24","author":[{"given":"Anelise Dutra","family":"Wallau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-19960201-03"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)91026-0"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20010501-09"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)98038-1"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.07.035"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(02)01701-7"},{"key":"e_1_3_1_8_2","first-page":"228","article-title":"Isolation of new fractions of antitumor mitomycins","volume":"8","author":"Wakaki S","year":"1958","unstructured":"Wakaki S, Marumo H, Tornoika K. Isolation of new fractions of antitumor mitomycins. Antibiot Chemother. 1958;8:228\u2013240.","journal-title":"Antibiot Chemother"},{"key":"e_1_3_1_9_2","first-page":"1315","volume-title":"Antineoplastic Agents","author":"Chabner B","year":"2005","unstructured":"Chabner B, Amrein P, Druker B, Michaelson M, Mitsiades C, Goss P, Ryan D, Ramachandra S, Richardson P, Supko J, Wilson W. Antineoplastic Agents. 11th ed. New York, NY: The Mc-Graw-Hill Companies Inc; 2005:1315.","edition":"11"},{"key":"e_1_3_1_10_2","first-page":"601","article-title":"Studies on the pterygium. Part 4: a treatment of the pterygium by mitomycin-C instillation [Japanese]","volume":"67","author":"Kunitomo N","year":"1963","unstructured":"Kunitomo N, Mori S. Studies on the pterygium. Part 4: a treatment of the pterygium by mitomycin-C instillation [Japanese]. Nippon Ganka Gakkai Zasshi. 1963;67:601\u2013607.","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01069-2"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200110000-00006"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01400-9"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90022-2"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20010501-08"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1991.01080080101040"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)00019-6"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200307000-00002"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20040301-14"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(03)00521-2"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1990.01070070051034"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20010901-21"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(98)00288-8"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200405000-00007"},{"key":"e_1_3_1_25_2","first-page":"S65","article-title":"Course of subepithelial corneal haze over 18 months after photorefractive keratectomy for myopia [corrected]","volume":"9","author":"Caubet E","year":"1993","unstructured":"Caubet E. Course of subepithelial corneal haze over 18 months after photorefractive keratectomy for myopia [corrected]. Refract Corneal Surg. 1993;9:S65\u2013S70.","journal-title":"Refract Corneal Surg"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)70433-7"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20040903-13"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20060601-08"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.06.015"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20051101-28"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2003.12.058"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00222-8"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(02)01507-9"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.03.061"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2005.10.033"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2006.01.002"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2005.08.022"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2005.05.027"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.04.029"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2005.06.051"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2003.12.044"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2004.09.043"}],"container-title":["Journal of Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/ophthalmology\/refractive-surgery\/journals\/jrs\/2008-4-24-4\/%7B84019cb6-7de2-4408-ac20-c173e1c850c4%7D\/photorefractive-keratectomy-with-mitomycin-c-versus-lasik-in-custom-surgeries-for-myopia-a-bilateral-prospective-randomized-clinical-trial","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T18:27:26Z","timestamp":1727202446000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/1081597X-20080401-03"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.3928\/1081597X-20080401-03"],"URL":"https:\/\/doi.org\/10.3928\/1081597x-20080401-03","relation":{},"ISSN":["1081-597X"],"issn-type":[{"type":"print","value":"1081-597X"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}